-
Je něco špatně v tomto záznamu ?
Cdx2 Animal Models Reveal Developmental Origins of Cancers
K. Chawengsaksophak,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
NLK
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2010
PubMed Central
od 2010
Europe PubMed Central
od 2010
ProQuest Central
od 2010-03-01
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
PubMed
31739541
DOI
10.3390/genes10110928
Knihovny.cz E-zdroje
- MeSH
- ezofágus patologie MeSH
- homeoboxové geny genetika MeSH
- kolon patologie MeSH
- lidé MeSH
- metaplazie genetika patologie MeSH
- modely nemocí na zvířatech MeSH
- nádory jícnu genetika patologie MeSH
- nádory tračníku genetika patologie MeSH
- nádory žaludku genetika patologie MeSH
- progrese nemoci MeSH
- regulace genové exprese u nádorů * MeSH
- transkripční faktor CDX2 genetika metabolismus MeSH
- žaludek patologie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
The Cdx2 homeobox gene is important in assigning positional identity during the finely orchestrated process of embryogenesis. In adults, regenerative responses to tissues damage can require a replay of these same developmental pathways. Errors in reassigning positional identity during regeneration can cause metaplasias-normal tissue arising in an abnormal location-and this in turn, is a well-recognized cancer risk factor. In animal models, a gain of Cdx2 function can elicit a posterior shift in tissue identity, modeling intestinal-type metaplasias of the esophagus (Barrett's esophagus) and stomach. Conversely, loss of Cdx2 function can elicit an anterior shift in tissue identity, inducing serrated-type lesions expressing gastric markers in the colon. These metaplasias are major risk factors for the later development of esophageal, stomach and colon cancer. Leukemia, another cancer in which Cdx2 is ectopically expressed, may have mechanistic parallels with epithelial cancers in terms of stress-induced reprogramming. This review will address how animal models have refined our understanding of the role of Cdx2 in these common human cancers.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20023486
- 003
- CZ-PrNML
- 005
- 20201214130151.0
- 007
- ta
- 008
- 201125s2019 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/genes10110928 $2 doi
- 035 __
- $a (PubMed)31739541
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Chawengsaksophak, Kallayanee $u Laboratory of Cell Differentiation, Institute of Molecular Genetics of the Czech Academy of Sciences, v.v.i. Vídenská 1083, 4 14220 Prague, Czech Republic.
- 245 10
- $a Cdx2 Animal Models Reveal Developmental Origins of Cancers / $c K. Chawengsaksophak,
- 520 9_
- $a The Cdx2 homeobox gene is important in assigning positional identity during the finely orchestrated process of embryogenesis. In adults, regenerative responses to tissues damage can require a replay of these same developmental pathways. Errors in reassigning positional identity during regeneration can cause metaplasias-normal tissue arising in an abnormal location-and this in turn, is a well-recognized cancer risk factor. In animal models, a gain of Cdx2 function can elicit a posterior shift in tissue identity, modeling intestinal-type metaplasias of the esophagus (Barrett's esophagus) and stomach. Conversely, loss of Cdx2 function can elicit an anterior shift in tissue identity, inducing serrated-type lesions expressing gastric markers in the colon. These metaplasias are major risk factors for the later development of esophageal, stomach and colon cancer. Leukemia, another cancer in which Cdx2 is ectopically expressed, may have mechanistic parallels with epithelial cancers in terms of stress-induced reprogramming. This review will address how animal models have refined our understanding of the role of Cdx2 in these common human cancers.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a transkripční faktor CDX2 $x genetika $x metabolismus $7 D000071616
- 650 _2
- $a kolon $x patologie $7 D003106
- 650 _2
- $a nádory tračníku $x genetika $x patologie $7 D003110
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a nádory jícnu $x genetika $x patologie $7 D004938
- 650 _2
- $a ezofágus $x patologie $7 D004947
- 650 12
- $a regulace genové exprese u nádorů $7 D015972
- 650 _2
- $a homeoboxové geny $x genetika $7 D005801
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a metaplazie $x genetika $x patologie $7 D008679
- 650 _2
- $a žaludek $x patologie $7 D013270
- 650 _2
- $a nádory žaludku $x genetika $x patologie $7 D013274
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 773 0_
- $w MED00174652 $t Genes $x 2073-4425 $g Roč. 10, č. 11 (2019)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31739541 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201214130150 $b ABA008
- 999 __
- $a ok $b bmc $g 1595805 $s 1114162
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 10 $c 11 $e 20191114 $i 2073-4425 $m Genes $n Genes $x MED00174652
- LZP __
- $a Pubmed-20201125